⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRMD News
CorMedix Inc.
Form 8-K
sec.gov
CRMD
Cormedix Announces FDA Acceptance for Priority Review of Supplemental NDA for Rezzayo® (Rezafungin) for Prophylaxis of Invasive Fungal Diseases
globenewswire.com
CRMD
Form 8-K
sec.gov
ATNM
CRMD
OVID
Actinium Pharmaceuticals Strengthens Leadership Team with Appointment of Matt David, M.D. as Chief Financial Officer
prnewswire.com
CRMD
OVID
ATNM
CorMedix Therapeutics to Participate in the Wells Fargo Healthcare Conference
globenewswire.com
CRMD
Today's Stocks in the News
globenewswire.com
CRMD
IVDA
DFSC
Form 8-K
sec.gov
CRMD
Cormedix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
CRMD
Form 8-K
sec.gov
CRMD
CREATE Medicines Expands Targeted In Vivo CAR Platform Through Strategic Research Collaboration and Exclusive License Agreement with Monash University
prnewswire.com
CRMD